DPQ: 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)- isoquinolinone; ANI: 4-amino-1,8-naphthalimidecan; PHHs: Primary human hepatocytes; PCR: Polymerase chain reaction; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; SNP: Single nucleotide polymorphism ,
HBV surface antigen; pADPr: ADP-ribose polymers ,
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, International Journal of Cancer, vol.8, issue.19, pp.2893-2917, 2010. ,
DOI : 10.1002/ijc.25516
Management of HCC, Journal of Hepatology, vol.56, issue.56, pp.75-87 ,
DOI : 10.1016/S0168-8278(12)60009-9
Innovative therapy for hepatocellular carcinoma: Three-dimensional high-dose photon radiotherapy, Cancer Letters, vol.286, issue.1, pp.129-133, 2009. ,
DOI : 10.1016/j.canlet.2008.12.004
Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies???mature results of the French Phase II RTF-1 trial, International Journal of Radiation Oncology*Biology*Physics, vol.66, issue.4, pp.1152-1158, 2006. ,
DOI : 10.1016/j.ijrobp.2006.06.015
DNA repair dysregulation from cancer driver to therapeutic target, Nature Reviews Cancer, vol.68, issue.12, pp.801-817, 2012. ,
DOI : 10.1038/nrc3399
The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art, Biochemical Pharmacology, vol.84, issue.2, pp.137-146, 2012. ,
DOI : 10.1016/j.bcp.2012.03.018
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets, Molecular Cell, vol.39, issue.1, pp.8-24, 2010. ,
DOI : 10.1016/j.molcel.2010.06.017
Targeting poly(ADP-ribose) polymerase activity for cancer therapy, Cellular and Molecular Life Sciences, vol.68, issue.Pt 2, pp.3649-3662, 2010. ,
DOI : 10.1007/s00018-010-0490-8
Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis, Molecular Cancer Therapeutics, vol.5, issue.3, pp.564-574, 2006. ,
DOI : 10.1158/1535-7163.MCT-05-0418
Replication-Dependent Radiosensitization of Human Glioma Cells by Inhibition of Poly(ADP-Ribose) Polymerase: Mechanisms and Therapeutic Potential, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.4, pp.1188-1197, 2008. ,
DOI : 10.1016/j.ijrobp.2008.07.031
PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility, Nucleic Acids Research, vol.36, issue.13, pp.4454-4464, 2008. ,
DOI : 10.1093/nar/gkn403
Role of cell cycle in mediating sensitivity to radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.4, pp.928-942, 2004. ,
DOI : 10.1016/j.ijrobp.2004.03.005
Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361, JNCI Journal of the National Cancer Institute, vol.96, issue.1, pp.56-67, 2004. ,
DOI : 10.1093/jnci/djh005
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?, Clinical Cancer Research, vol.15, issue.19, pp.6106-6112, 2009. ,
DOI : 10.1158/1078-0432.CCR-09-0398
A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia, Radiotherapy and Oncology, vol.88, issue.2, pp.258-268, 2008. ,
DOI : 10.1016/j.radonc.2008.04.005
Role of PARP Inhibitors in Cancer Biology and Therapy, Current Medicinal Chemistry, vol.19, issue.23, pp.3907-3921 ,
DOI : 10.2174/092986712802002464
Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression, Hepatology, vol.39, issue.Suppl 1, pp.255-266, 2010. ,
DOI : 10.1002/hep.23249
Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells, Cancer Letters, vol.301, issue.1, pp.47-56, 2011. ,
DOI : 10.1016/j.canlet.2010.10.026
Update on hepatocellular carcinoma breakthroughs: Poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy, Clinics and Research in Hepatology and Gastroenterology, vol.38, issue.2, pp.137-142, 2014. ,
DOI : 10.1016/j.clinre.2013.07.006
Nonlinear partial differential equations and applications: Infection of a human hepatoma cell line by hepatitis B virus, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15655-15660, 2002. ,
DOI : 10.1073/pnas.232137699
A microarray to measure repair of damaged plasmids by cell lysates, Lab on a Chip, vol.43, issue.10, pp.1713-1722, 2008. ,
DOI : 10.1039/b806634e
Aging and photo-aging DNA repair phenotype of skin cells???Evidence toward an effect of chronic sun-exposure, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.736, issue.1-2, pp.48-55, 2012. ,
DOI : 10.1016/j.mrfmmm.2011.05.005
Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines, British Journal of Cancer, vol.65, issue.2, pp.256-262, 2009. ,
DOI : 10.1016/0167-4889(93)90179-S
PARP1 Val762Ala polymorphism reduces enzymatic activity, Biochemical and Biophysical Research Communications, vol.354, issue.1, pp.122-126, 2007. ,
DOI : 10.1016/j.bbrc.2006.12.162
The ADPRT V762A Genetic Variant Contributes to Prostate Cancer Susceptibility and Deficient Enzyme Function, Cancer Research, vol.64, issue.17, pp.6344-6348, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-0338
The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes, Carcinogenesis, vol.33, issue.3, pp.581-586, 2012. ,
DOI : 10.1093/carcin/bgr300
Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types, Genes & Cancer, vol.1, issue.8, pp.812-821, 2010. ,
DOI : 10.1177/1947601910383418
Assessment of PARP-3 Distribution in Tissues of Cynomolgous Monkeys, Journal of Histochemistry & Cytochemistry, vol.48, issue.7, pp.675-685, 2009. ,
DOI : 10.1369/jhc.2009.953380
Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome, Int J Cancer, vol.133, pp.2791-2800, 2013. ,
Reduced ADP-ribosylation by PARP1 natural polymorphism V762A and by PARP1 inhibitors enhance Hepatitis B virus replication, Journal of Viral Hepatitis, vol.56, issue.1, pp.658-665, 2013. ,
DOI : 10.1111/jvh.12100
Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases, Hepatology, vol.65, issue.6, pp.1840-1851, 2012. ,
DOI : 10.1002/hep.25566